According to Sientra's latest financial reports the company's current earnings (TTM) are -$49.53 M. In 2022 the company made an earning of -$64.17 M a decrease over its 2021 earnings that were of -$54.25 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$49.53 M | -22.82% |
2022 | -$64.17 M | 18.3% |
2021 | -$54.25 M | -25.76% |
2020 | -$73.07 M | -28.52% |
2019 | -$0.11 B | 29.05% |
2018 | -$79.21 M | 26.09% |
2017 | -$62.82 M | 57.01% |
2016 | -$40.01 M | 4.91% |
2015 | -$38.14 M | 947.9% |
2014 | -$3.64 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Edwards Lifesciences EW | $1.61 B | -3,362.33% | ๐บ๐ธ USA |
iRadimed IRMD | $21.73 M | -143.89% | ๐บ๐ธ USA |
Cardiovascular Systems CSII | -$37.73 M | -23.83% | ๐บ๐ธ USA |
West Pharmaceutical WST | $0.69 B | -1,509.36% | ๐บ๐ธ USA |